수산양식용 백신 시장 규모, 점유율, 성장 분석 : 제품별, 투여 경로별, 용도별, 지역별 - 업계 예측(2026-2033년)

Global Aquaculture Vaccine Market size was valued at USD 230.91 Million in 2024 and is poised to grow from USD 248.46 Million in 2025 to USD 446.43 Million by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global aquaculture vaccine market is poised for significant growth driven by escalating bacterial and viral infections among aquaculture species, compelling producers to adopt vaccination strategies. The development and introduction of innovative vaccines targeting various viral diseases are crucial for enhancing market revenue. A notable shift is occurring, moving from traditional live attenuated vaccines towards DNA and recombinant vaccines, reflecting industry evolution. Increased investment in research and development of novel vaccines further supports this expansion. Additionally, rising aquaculture production and a growing consumer preference for seafood products heighten the demand for effective vaccination solutions. Numerous key players from both aquaculture and broader animal health sectors are reallocating resources to meet these essential needs, showcasing the dynamic nature of this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aquaculture Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aquaculture Vaccine Market Segments Analysis

Global Aquaculture Vaccine Market is segmented by Product, Route of Administration, Application and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Oral, Injected and Immersion & Spray. Based on Application, the market is segmented into Bacterial, Viral, Parasitic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aquaculture Vaccine Market

The Global Aquaculture Vaccine market is poised for growth due to rising fish mortality rates attributed to various disease outbreaks, which create an urgent demand for effective vaccination solutions. The increasing global appetite for fish as a source of animal protein, coupled with substantial government backing for vaccination initiatives in aquaculture, further fuels this expansion. Additionally, a rising adoption of vaccines in both established and emerging markets is expected to enhance market dynamics. Increased international trade of aquaculture species will also play a crucial role in driving market advancements, positioning aquaculture vaccines as essential in sustainable fish farming practices worldwide.

Restraints in the Global Aquaculture Vaccine Market

The development of cost-effective adjuvants and antigens that comply with stringent environmental and regulatory standards can significantly influence the market dynamics of aquaculture vaccines. This adherence to necessary guidelines often leads to increased production costs and complexities, ultimately hindering vaccination sales within the sector. Consequently, these challenges may restrict the market share for aquaculture vaccines, as manufacturers must navigate the balance between ensuring product efficacy and meeting compliance demands. The combination of these factors can create obstacles for industry growth, impacting both supply and demand in the aquaculture vaccine market.

Market Trends of the Global Aquaculture Vaccine Market

The Global Aquaculture Vaccine market is experiencing a significant upward trend driven by advancements in technology, heightened awareness of aquaculture diseases, and increased public-private partnerships aimed at research and development. Innovations in diagnostics and therapeutics, particularly in developing regions, alongside rising healthcare expenditure, are poised to propel market growth. Moreover, the proliferation of strategic alliances and collaborations within the industry, combined with the escalating concerns over zoonotic diseases, further amplify the demand for aquaculture vaccines. The overall market is expected to thrive as these factors converge, paving the way for sustained growth in this vital sector of the food production industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Aquaculture Vaccine Market Size by Product & CAGR (2026-2033)

• Market Overview
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global Aquaculture Vaccine Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injected
• Immersion & Spray

Global Aquaculture Vaccine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Bacterial
• Viral
• Parasitic
• Others

Global Aquaculture Vaccine Market Size & CAGR (2026-2033)

• North America (Product, Route of Administration, Application)
  • US
  • Canada
• Europe (Product, Route of Administration, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hipra (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AquaBounty Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchmark Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaq AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KBNP (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nisseiken Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Biken Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cavac (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VETERQUIMICA SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations